CCM
BMY icon

Campbell Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Campbell Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-350
Closed -$21.3K – 56
2025
Q1 		$21.3K Hold
350
– – 0.01% 49
2024
Q4 		$19.8K Buy
+350
New +$19.6K 0.01% 71
2022
Q1 		– Sell
-95,857
Closed -$5.98M – 40
2021
Q4 		$5.98M Sell
95,857
-4,750
-5% -$279K 2.47% 14
2021
Q3 		$5.95M Sell
100,607
-4,060
-4% -$267K 2.61% 14
2021
Q2 		$6.99M Sell
104,667
-1,700
-2% -$111K 3.16% 9
2021
Q1 		$6.71M Sell
106,367
-914
-0.9% -$56.9K 3.09% 12
2020
Q4 		$7.02M Buy
107,281
+122
+0.1% +$7.5K 3.45% 8
2020
Q3 		$6.46M Buy
107,159
+60,550
+130% +$3.64M 3.7% 8
2020
Q2 		$2.74M Buy
46,609
+3,840
+9% +$230K 1.91% 16
2020
Q1 		$2.38M Sell
42,769
-2,140
-5% -$131K 2.45% 13
2019
Q4 		$2.88M Sell
44,909
-650
-1% -$37.2K 1.77% 19
2019
Q3 		$2.31M Buy
45,559
+14,200
+45% +$667K 1.72% 21
2019
Q2 		$1.42M Sell
31,359
-1,200
-4% -$55.9K 1.13% 23
2019
Q1 		$1.55M Sell
32,559
-200
-0.6% -$9.96K 1.12% 24
2018
Q4 		$1.7M Buy
+32,759
New +$1.76M 2.17% 14

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell Capital Management's BMY Position: Q2 2025 in Review

Campbell Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 350 shares — an estimated $21.3K sold.

Campbell Capital Management first reported a position in BMY in Q4 2018 and held it in 15 quarters. The position peaked at $7.02M in Q4 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Campbell Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Campbell Capital Management sold 350 Bristol-Myers Squibb shares in Q2 2025, an estimated $21.3K.
  • Campbell Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 15 quarters.
  • Campbell Capital Management's Bristol-Myers Squibb position peaked at $7.02M in Q4 2020.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Campbell Capital Management's 13F filing for Q2 2025, filed 19 Aug 2025.